Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
40 participants
INTERVENTIONAL
2023-08-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Domperidon
Participants recieve 10mg of Domperidon, 45 minutes before the start of the experiment
Domperidon
oral
Placebo
Participants recieve a placebo pill, 45 minutes before the start of the experiment
Placebo
oral tablet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Domperidon
oral
Placebo
oral tablet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Consent to participate
* Fluent in German
* Physically and mentally healthy. No regular medication
* BMI 18-25 kg/m2
* Alcohol consumption less than 15 glasses a week (wine / beer, a glass of higher-percentage alcohol counts as two glasses of beer)
* No illegal drug consumption in the week previous to the experiment
* No smoking
* No extreme athletes
* No vegetarians or vegans or any other dietary restrictions due to allergies or intolerances
* Normal day-night rhythm (no shift work)
Exclusion Criteria
* Brain or mind (including anxiety disorders, depression, eating disorders, personality disorders, alcohol, drugs or drug dependence, neurological disorders other than occasional headache, psychiatric or neurological abnormalities)
* Heart or blood circulation
* Gastro-intestinal or endocrine disorders
* Other serious past or present medical conditions (for example, metabolic syndrome, diabetes).
* Current medication and medication over a period of two weeks prior to the examination.
* Other serious health problems or present strong mental or physical stress.
* No current infection or excessive stress
* Missing consent to receive information about incidental findings from the MRI
* Tendency to claustrophobia, dizziness or panic attacks.
* Wear a non-removable pacemaker, defibrillator, hearing aid, drug pump, neurostimulator or implant with solenoid valve (e.g., artificial bowel outlet).
* Metal parts or implants inside the body, for example, due to surgery or injury with a metallic foreign object (e.g., hip replacements, artificial joints, heart valves, vessel occlusions or dilatations, surgical clips, bone screws or plates, coil, shunts, catheters, electrodes, coils, radiation sources, shrapnel, projectiles, stents).
* Have non-removable metal parts or metal-containing devices on or in the body.
* Have ferromagnetic metal parts or implants inside the body (e.g., hip replacements, artificial joints, heart valves, vessel occlusions or dilatations, surgical clips, bone screws or plates, coils, shunts, catheters, electrodes, coils, radiation sources, shrapnel, projectiles, stents)
* Wearing magnetically fixed implants (e.g., amalgam fillings, glass eye).
* Professionally or privately being involved in the processing of metals.
* Have large tattoos (whole limbs).
* Being pregnant.
* Wear a intra-uterine device.
* Having tinnitus.
* Hypersensitivity or allergy to Domperidone or common excipients (lactose-1, corn Starch, potato starch, microcrystalline cellulose, castor oil, povidone, sodium lauryl sulfate, magnesium stearate, hypromellose)
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Institute of Human Nutrition
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Soyoung Q Park
Prof. Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
German Institute of Human Nutrition
Potsdam, Brandenburg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ignacio Rebollo
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Domperidone emotions
Identifier Type: -
Identifier Source: org_study_id